US EditionPublished • loading... • Updated
New Research Highlights Syntax Bio’s Platform for Simple Yet Powerful Programming of Human Stem Cells
Summary by Joplin Globe
2 Articles
2 Articles
Syntax Bio Develops CRISPR Technology to Program Stem Cell Gene Activity
Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced the publication of new research in Science Advances detailing the company's CRISPR-based Cellgorithm™ technology, which lays the groundwork for programmable control of gene activity in human stem cells and offers an alternative to the slow, variable manual processes researchers use today.
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center1Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
